Identification of putative pathogenic single nucleotide variants (SNVs) in genes associated with heart disease in 290 cases of stillbirth.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 06 07 2018
accepted: 14 12 2018
entrez: 8 1 2019
pubmed: 8 1 2019
medline: 1 10 2019
Statut: epublish

Résumé

The incidence of stillbirth in Sweden has essentially remained constant since the 1980's, and despite thorough investigation, many cases remain unexplained. It has been suggested that a proportion of stillbirth cases is caused by heart disease, mainly channelopathies. The aim of this study was to analyze DNA from 290 stillbirth cases without chromosomal abnormalities for pathogenic single nucleotide variants (SNVs) in 70 genes associated with cardiac channelopathies and cardiomyopathies. The HaloPlex Target Enrichment System (Agilent Technologies) was utilized to prepare sequencing libraries which were sequenced on the Illumina NextSeq platform. We found that 12.1% of the 290 investigated stillbirth cases had one (n = 31) or two (n = 4) variants with evidence supporting pathogenicity, i.e. loss-of-function variants (nonsense, frameshift, splice site substitutions), evidence from functional studies, or previous identification of the variants in affected individuals. Regarding identified putative pathogenic variants in genes associated with channelopathies, the prevalence was significantly higher in the stillbirth cohort (n = 23, 7.93%) than the corresponding prevalence of the same variants in the non-Finnish European population of the Exome Aggregation Consortium (2.70%, p<0.001) and SweGen, (2.30%, p<0.001). Our results give further support to the hypothesis that cardiac channelopathies might contribute to stillbirth. Screening for pathogenic SNVs in genes associated with heart disease might be a valuable complement for stillbirth cases where today's conventional investigation does not reveal the underlying cause of fetal demise.

Identifiants

pubmed: 30615648
doi: 10.1371/journal.pone.0210017
pii: PONE-D-18-20096
pmc: PMC6322759
doi:

Substances chimiques

Codon, Nonsense 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0210017

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Genet Med. 2017 Oct;19(10):1151-1158
pubmed: 28518168
Forensic Sci Int. 2010 Jan 30;194(1-3):e21-4
pubmed: 19931342
Fetal Diagn Ther. 2013;33(1):1-7
pubmed: 22776830
Genet Med. 2017 Feb;19(2):192-203
pubmed: 27532257
Fetal Diagn Ther. 2014;36(4):326-32
pubmed: 25059832
N Engl J Med. 2012 Dec 6;367(23):2185-93
pubmed: 23215556
Eur J Hum Genet. 2012 Aug;20(8):905-8
pubmed: 22378279
Heart Rhythm. 2009 Feb;6(2):272-8
pubmed: 18823823
Acta Obstet Gynecol Scand. 2002 Apr;81(4):284-92
pubmed: 11952456
BMJ. 2015 Jun 24;350:h3080
pubmed: 26109551
Circulation. 2007 Jan 23;115(3):361-7
pubmed: 17210839
Clin Obstet Gynecol. 2010 Sep;53(3):628-34
pubmed: 20661047
JAMA. 2013 Apr 10;309(14):1473-82
pubmed: 23571586
Korean J Pediatr. 2014 Jan;57(1):1-18
pubmed: 24578711
J Mol Diagn. 2015 Jan;17(1):31-42
pubmed: 25445213
Circulation. 2018 Sep 18;138(12):1195-1205
pubmed: 29959160
Int J Legal Med. 2016 Mar;130(2):415-20
pubmed: 26872470
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Forensic Sci Int. 2012 Jun 10;219(1-3):278-81
pubmed: 22361390
Cardiology. 2011;119(1):21-33
pubmed: 21778721
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Eur J Hum Genet. 2016 Jun;24(6):817-22
pubmed: 26350513
Eur J Hum Genet. 2017 Nov;25(11):1253-1260
pubmed: 28832569
Circulation. 2007 Nov 13;116(20):2253-9
pubmed: 17967976
Eur J Hum Genet. 2013 Sep;21(9):918-28
pubmed: 23299917
Acta Obstet Gynecol Scand. 2008;87(11):1202-12
pubmed: 18951207
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
World J Cardiol. 2014 Jun 26;6(6):478-94
pubmed: 24976920

Auteurs

Ellika Sahlin (E)

Department of Molecular Medicine and Surgery and Center for Molecular Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

Anna Gréen (A)

Department of Clinical Pathology and Clinical Genetics, and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.

Peter Gustavsson (P)

Department of Molecular Medicine and Surgery and Center for Molecular Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

Agne Liedén (A)

Department of Molecular Medicine and Surgery and Center for Molecular Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

Magnus Nordenskjöld (M)

Department of Molecular Medicine and Surgery and Center for Molecular Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

Nikos Papadogiannakis (N)

Center for Perinatal Pathology and Department of Pathology, Karolinska University Hospital, Huddinge and Karolinska Institutet, Stockholm, Sweden.

Karin Pettersson (K)

Department of Obstetrics and Gynecology, Karolinska University Hospital, Huddinge and Karolinska Institutet, Stockholm, Sweden.

Daniel Nilsson (D)

Department of Molecular Medicine and Surgery and Center for Molecular Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

Jon Jonasson (J)

Department of Clinical Pathology and Clinical Genetics, and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.

Erik Iwarsson (E)

Department of Molecular Medicine and Surgery and Center for Molecular Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH